CFTR modulators and ganglioside GM1: a new combination for the treatment of cystic fibrosis

被引：0
|
作者：
Dobi, D. [1 ]
Loberto, N. [1 ]
Bassi, R. [1 ]
Mauri, L. [1 ]
Dechecchi, M. C. [2 ]
Tedesco, E. [3 ]
Olioso, D. [2 ]
Cabrini, G. [4 ]
Lippi, G. [2 ]
Pedemonte, N. [5 ]
Tamanini, A. [3 ]
Aureli, M. [1 ]
机构：
[1] Univ Milan, Dept Med Biotechnol & Translat Med, Segrate, Italy
[2] Univ Verona, Dept Neurosci Biomed & Movement, Sect Clin Biochem, Verona, Italy
[3] Univ Hosp Verona, Dept Pathol & Diagnost, Sect Mol Pathol, Verona, Italy
[4] Univ Ferrara, Dept Life Sci & Biotechnol, Innthera4CF, Ferrara, Italy
[5] UOC Genet Med, Ist Giannina Gaslini, Genoa, Italy
来源：
FEBS OPEN BIO | 2022年 / 12卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-04.2-011
引用
收藏
页码：270 / 271
页数：2
相关论文
共 50 条
  • [11] An Update on CFTR Modulators as New Therapies for Cystic Fibrosis
    John A. King
    Anna-Louise Nichols
    Sian Bentley
    Siobhan B. Carr
    Jane C. Davies
    Pediatric Drugs, 2022, 24 : 321 - 333
  • [12] An Update on CFTR Modulators as New Therapies for Cystic Fibrosis
    King, John A.
    Nichols, Anna-Louise
    Bentley, Sian
    Carr, Siobhan B.
    Davies, Jane C.
    PEDIATRIC DRUGS, 2022, 24 (04) : 321 - 333
  • [13] Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
    Zhang, Wenchao
    Krafft, Paul R.
    Wang, Tianlong
    Zhang, John H.
    Li, Li
    Tang, Jiping
    CELL TRANSPLANTATION, 2019, 28 (06) : 657 - 661
  • [14] PROPERTIES OF ANTISERA TO GANGLIOSIDE GM1 AND ASIALO GM1
    NAIKI, M
    MARCUS, DM
    LEDEEN, R
    JOURNAL OF IMMUNOLOGY, 1974, 113 (01): : 84 - 93
  • [15] PULMONOLOGY CFTR modulators for cystic fibrosis
    Bertoncini, Erica
    Colomb-Lippa, Dawn
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2013, 26 (02): : 59 - 60
  • [16] GM1 ganglioside in the treatment of Parkinson's disease
    Schneider, JS
    SPHINGOLIPIDS AS SIGNALING MODULATORS IN THE NERVOUS SYSTEM, 1998, 845 : 363 - 373
  • [17] Efficacy of Ganglioside GM1 in the Treatment of Postherpetic Neuralgia
    Koju, Ram Prasad
    Lei, Tie-Chi
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2016, 26 (07): : 633 - 634
  • [18] Triplet CFTR modulators: future prospects for treatment of cystic fibrosis
    Chaudary, Nauman
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 2375 - 2383
  • [19] Challenges in the treatment of cystic fibrosis in the era of CFTR modulators Reply
    Ribeiro Ferreira da Silva Filho, Luiz Vicente
    Athanazio, Rodrigo Abensur
    Tonon, Carolina Rodrigues
    Ferreira, Juliana Carvalho
    Tanni, Suzana Erico
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2024, 50 (02)
  • [20] SUSCEPTIBILITY OF GANGLIOSIDE GM1 TO A NEW BACTERIAL NEURAMINIDASE
    SUGANO, K
    SAITO, M
    NAGAI, Y
    FEBS LETTERS, 1978, 89 (02) : 321 - 325
12345